Avadel Pharmaceuticals

Avadel Pharmaceuticals is a biopharmaceutical company developing medicines to address the challenges patients face with current treatment options.

lawsuit
Pharma

FDA faces lawsuit from Jazz after approval of Avadel's sleep aid

Jazz is suing the FDA, challenging the regulator for approving Avadel's Lumryz which poses a threat to Jazz's blockbuster Xyrem/Xywav franchise.
Kevin Dunleavy Jun 23, 2023 11:38am
Narcolepsy

FDA endorses Avadel's Lumryz, a major threat to Jazz's Xyrem

May 2, 2023 8:00am
FTC building

In Jazz case, FTC urges court to delist patent on Xyrem

Nov 14, 2022 9:40am
FDA Building

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Jul 26, 2022 7:50am